InsidersTradesSigma
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by Clark Eliana, Directeur Exécutif, Technologie. Director active across 1 company, notably Intellia Therapeutics, Inc.. Cumulatively, 11 reports have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €51k. History available since 1 March 2022. The latest transaction was disclosed on 1 July 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
11 of 11 declarations
Eliana Clark is the Executive Vice President and Chief Technical Officer at Intellia Therapeutics, Inc. She oversees technological development and innovation within the company. Clark plays a vital role in implementing new technologies and improving products.